Supplemental Information (Tables)

6 Months Ended

Jun. 30, 2024

Product Information [Line Items]

Schedule of Discontinued Operation

A summary of the Lyte discontinued operation in the condensed consolidated statement of operations and comprehensive loss for the three and six months ended June 30, 2023 is set forth below:

	Three			Six
	Months Ended June 30, 2023			Months Ended June 30, 2023
Net revenues	$	2,192		$	5,594
Cost of revenues		2,272			5,386
Gross profit		(80	)		208
Operating expenses:
Sales and marketing		331			603
General and administrative		496			1,069
Impairment of goodwill		1,203			1,203
Total operating expenses		2,030			2,875
Operating loss	$	(2,110	)	$	(2,667	)

Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

The following table sets forth common stock equivalents that have been excluded from the computation of dilutive weighted average shares outstanding as their inclusion would have been anti-dilutive:

	June 30,
	2024		2023
Warrants		-		125,103
Options		8,323		18,091
Restricted stock units		70,223		96,878
Total		78,546		240,072

Accounts Receivable [Member]

Product Information [Line Items]

Schedule of Concentration of Credit Risk of Accounts Receivable

Collateral is not required for accounts receivable, and we believe the carrying value approximates fair value. The following table sets forth our concentration of accounts receivable, net of specific allowances for doubtful accounts.

	June 30, 2024			December 31, 2023
Customer A		0	%		43	%
Customer B		12	%		16	%
Customer C		3	%		12	%
Customer D		36	%		0	%
Customer E		17	%		0	%